Literature DB >> 31141140

Adjuvant Therapy for Ampullary Cancer.

Andrew H Ko1,2, Eric K Nakakura2,3.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31141140     DOI: 10.1001/jamasurg.2019.1171

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  3 in total

Review 1.  Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review.

Authors:  Zhiqing Duan; Yinuo Zhang; Yajie Tang; Ruqing Gao; Jing Bao; Bo Liang
Journal:  Transl Oncol       Date:  2022-04-06       Impact factor: 4.243

2.  Remission from the 5-Fu-Based Chemotherapy to Gemcitabine-Based Chemotherapy-Based on the Pathological Classification of Periampullary Carcinoma: A Case Report and Literature Review.

Authors:  Wei Hu; Zhiqing Duan; Yinuo Zhang; Jing Liu; Jing Bao; Ruqing Gao; Yajie Tang; Tiande Liu; Hu Xiong; Wen Li; Xiaowei Fu; Shousheng Liao; Lu Fang; Bo Liang
Journal:  Onco Targets Ther       Date:  2022-08-25       Impact factor: 4.345

3.  Defects of endoscopic biopsy in the diagnosis of periampullary carcinoma and recommendations for diagnosis and treatment: a retrospective study before and after surgery.

Authors:  Yinuo Zhang; Zhiqing Duan; Xiaoyu Yu; Yuzhu Zhang; Jing Liu; Shousheng Liao; Bo Liang
Journal:  Gland Surg       Date:  2022-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.